{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:09:57Z","timestamp":1790291397485,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7603","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/nature17967","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T09:14:17Z","timestamp":1463562857000},"page":"338-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":323,"title":["A platform for the discovery of new macrolide antibiotics"],"prefix":"10.1038","volume":"533","author":[{"given":"Ian B.","family":"Seiple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Jakubec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Langlois-Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Hog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Yabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senkara Rao","family":"Allu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Fukuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Condakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip T.","family":"Szczypi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"BFnature17967_CR1","doi-asserted-by":"crossref","unstructured":"Walsh, C. Antibiotics: Actions, Origins, Resistance (American Society for Microbiology Press, 2003)","DOI":"10.1128\/9781555817886"},{"key":"BFnature17967_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach, M. A. & Walsh, C. T. Antibiotics for emerging pathogens. Science 325, 1089\u20131093 (2009)","journal-title":"Science"},{"key":"BFnature17967_CR3","doi-asserted-by":"publisher","first-page":"8840","DOI":"10.1002\/anie.201310843","volume":"53","author":"PM Wright","year":"2014","unstructured":"Wright, P. M., Seiple, I. B. & Myers, A. G. The evolving role of chemical synthesis in antibacterial drug discovery. Angew. Chem. Int. Ed. 53, 8840\u20138869 (2014)","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnature17967_CR4","first-page":"281","volume":"2","author":"JM Mcguire","year":"1952","unstructured":"Mcguire, J. M. et al. Ilotycin, a new antibiotic. Antibiot. Chemother. 2, 281\u2013283 (1952)","journal-title":"Antibiot. Chemother."},{"key":"BFnature17967_CR5","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1021\/ja00401a051","volume":"103","author":"RB Woodward","year":"1981","unstructured":"Woodward, R. B. et al. Asymmetric total synthesis of erythromycin. 3. Total synthesis of erythromycin. J. Am. Chem. Soc. 103, 3215\u20133217 (1981)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature17967_CR6","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1021\/ja963575y","volume":"119","author":"SF Martin","year":"1997","unstructured":"Martin, S. F., Hida, T., Kym, P. R., Loft, M. & Hodgson, A. The asymmetric synthesis of erythromycin B. J. Am. Chem. Soc. 119, 3193\u20133194 (1997)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature17967_CR7","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/anie.200805334","volume":"48","author":"HC Kim","year":"2009","unstructured":"Kim, H. C. & Kang, S. H. Total synthesis of azithromycin. Angew. Chem. Int. Ed. 48, 1827\u20131829 (2009)","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnature17967_CR8","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1055\/s-0034-1381047","volume":"26","author":"RB Andrade","year":"2015","unstructured":"Andrade, R. B. Total synthesis of desmethyl macrolide antibiotics. Synlett 26, 2199\u20132215 (2015)","journal-title":"Synlett"},{"key":"BFnature17967_CR9","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1021\/cr960027u","volume":"97","author":"C Khosla","year":"1997","unstructured":"Khosla, C. Harnessing the biosynthetic potential of modular polyketide synthases. Chem. Rev. 97, 2577\u20132590 (1997)","journal-title":"Chem. Rev."},{"key":"BFnature17967_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.282.5386.63","volume":"282","author":"DE Cane","year":"1998","unstructured":"Cane, D. E., Walsh, C. T. & Khosla, C. Harnessing the biosynthetic code: combinations, permutations, and mutations. Science 282, 63\u201368 (1998)","journal-title":"Science"},{"key":"BFnature17967_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1126\/science.279.5348.199","volume":"279","author":"AFA Marsden","year":"1998","unstructured":"Marsden, A. F. A. et al. Engineering broader specificity into an antibiotic-producing polyketide synthase. Science 279, 199\u2013202 (1998)","journal-title":"Science"},{"key":"BFnature17967_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00253-009-2326-8","volume":"85","author":"SR Park","year":"2010","unstructured":"Park, S. R. et al. Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects. Appl. Microbiol. Biotechnol. 85, 1227\u20131239 (2010)","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"BFnature17967_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/BF02137246","volume":"27","author":"P Kurath","year":"1971","unstructured":"Kurath, P., Jones, P. H., Egan, R. S. & Perun, T. J. Acid degradation of erythromycin A and erythromycin B. Experientia 27, 362 (1971)","journal-title":"Experientia"},{"key":"BFnature17967_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.7164\/antibiotics.41.1029","volume":"41","author":"GM Bright","year":"1988","unstructured":"Bright, G. M. et al. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives \u2013 a new class of macrolide antibiotics, the azalides. J. Antibiot. (Tokyo) 41, 1029\u20131047 (1988)","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFnature17967_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7164\/antibiotics.37.187","volume":"37","author":"S Morimoto","year":"1984","unstructured":"Morimoto, S., Takahashi, Y., Watanabe, Y. & Omura, S. Chemical modification of erythromycins. 1. Synthesis and antibacterial activity of 6-O-methylerythromycins-A. J. Antibiot. (Tokyo) 37, 187\u2013189 (1984)","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFnature17967_CR16","unstructured":"Fernandes, P. B. Methods for treating gastrointestinal diseases. WO patent 2010\/048599 (2010)"},{"key":"BFnature17967_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.diagmicrobio.2009.10.013","volume":"66","author":"SD Putnam","year":"2010","unstructured":"Putnam, S. D., Castanheira, M., Moet, G. J., Farrell, D. J. & Jones, R. N. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 66, 393\u2013401 (2010)","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"BFnature17967_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq, R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34, 482\u2013492 (2002)","journal-title":"Clin. Infect. Dis."},{"key":"BFnature17967_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2174\/1568026033452159","volume":"3","author":"M Gaynor","year":"2003","unstructured":"Gaynor, M. & Mankin, A. S. Macrolide antibiotics: binding site, mechanism of action, resistance. Curr. Top. Med. Chem. 3, 949\u2013961 (2003)","journal-title":"Curr. Top. Med. Chem."},{"key":"BFnature17967_CR20","doi-asserted-by":"crossref","unstructured":"Subramanian, S. L., Ramu, H. & Mankin, A. S. in Antibiotic Discovery and Development (eds Dougherty, T. J. & Pucci, M. J. ) 455\u2013484 (Springer, 2012)","DOI":"10.1007\/978-1-4614-1400-1_13"},{"key":"BFnature17967_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1469-0691.2000.00185.x","volume":"6","author":"A Bryskier","year":"2000","unstructured":"Bryskier, A. Ketolides-telithromycin, an example of a new class of antibacterial agents. Clin. Microbiol. Infect. 6, 661\u2013669 (2000)","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnature17967_CR22","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2165\/00003495-200262120-00006","volume":"62","author":"GG Zhanel","year":"2002","unstructured":"Zhanel, G. G. et al. The ketolides: a critical review. Drugs 62, 1771\u20131804 (2002)","journal-title":"Drugs"},{"key":"BFnature17967_CR23","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1128\/AAC.31.12.1939","volume":"31","author":"J Retsema","year":"1987","unstructured":"Retsema, J. et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob. Agents Chemother. 31, 1939\u20131947 (1987)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature17967_CR24","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1128\/AAC.31.12.1948","volume":"31","author":"AE Girard","year":"1987","unstructured":"Girard, A. E. et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob. Agents Chemother. 31, 1948\u20131954 (1987)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature17967_CR25","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/S0960-894X(98)00402-8","volume":"8","author":"A Denis","year":"1998","unstructured":"Denis, A. & Agouridas, C. Synthesis of 6-O-methyl-azithromycin and its ketolide analog via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime. Bioorg. Med. Chem. Lett. 8, 2427\u20132432 (1998)","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnature17967_CR26","doi-asserted-by":"publisher","first-page":"8286","DOI":"10.1021\/ja00203a044","volume":"111","author":"RK Boeckman Jr","year":"1989","unstructured":"Boeckman, R. K., Jr & Pruitt, J. R. A new, highly efficient, selective methodology for formation of medium-ring and macrocyclic lactones via intramolecular ketene trapping: an application to a convergent synthesis of (\u2013)-kromycin. J. Am. Chem. Soc. 111, 8286\u20138288 (1989)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature17967_CR27","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1021\/jo00376a101","volume":"51","author":"RK Boeckman Jr","year":"1986","unstructured":"Boeckman, R. K. Jr & Perni, R. B. Studies directed toward the synthesis of naturally occurring acyltetramic acids. 2. Preparation of the macrocyclic subunit of ikarugamycin. J. Org. Chem. 51, 5486\u20135489 (1986)","journal-title":"J. Org. Chem."},{"key":"BFnature17967_CR28","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1021\/ja00401a050","volume":"103","author":"RB Woodward","year":"1981","unstructured":"Woodward, R. B. et al. Asymmetric total synthesis of erythromycin. 2. Synthesis of an erythronolide A lactone system. J. Am. Chem. Soc. 103, 3213\u20133215 (1981)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature17967_CR29","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","volume":"41","author":"VV Rostovtsev","year":"2002","unstructured":"Rostovtsev, V. V., Green, L. G., Fokin, V. V. & Sharpless, K. B. A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes. Angew. Chem. Int. Ed. 41, 2596\u20132599 (2002)","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnature17967_CR30","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1128\/JB.185.14.4276-4279.2003","volume":"185","author":"R Berisio","year":"2003","unstructured":"Berisio, R. et al. Structural insight into the antibiotic action of telithromycin against resistant mutants. J. Bacteriol. 185, 4276\u20134279 (2003)","journal-title":"J. Bacteriol."},{"key":"BFnature17967_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2005.02.005","volume":"121","author":"D Tu","year":"2005","unstructured":"Tu, D., Blaha, G., Moore, P. B. & Steitz, T. A. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121, 257\u2013270 (2005)","journal-title":"Cell"},{"key":"BFnature17967_CR32","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00860-10","volume":"54","author":"B Llano-Sotelo","year":"2010","unstructured":"Llano-Sotelo, B. et al. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. Antimicrob. Agents Chemother. 54, 4961\u20134970 (2010)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature17967_CR33","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1073\/pnas.1008685107","volume":"107","author":"D Bulkley","year":"2010","unstructured":"Bulkley, D., Innis, C. A., Blaha, G. & Steitz, T. A. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc. Natl Acad. Sci. USA 107, 17158\u201317163 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17967_CR34","doi-asserted-by":"publisher","first-page":"E5805","DOI":"10.1073\/pnas.1517952112","volume":"112","author":"Z Eyal","year":"2015","unstructured":"Eyal, Z. et al. Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus. Proc. Natl Acad. Sci. USA 112, E5805\u2013E5814 (2015)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17967_CR35","first-page":"57","volume":"27","author":"IB Seiple","year":"2016","unstructured":"Seiple, I. B., Hog, D. T. & Myers, A. G. Practical protocols for the preparation of highly enantioenriched silyl ethers of (R)-3-hydroxypentan-2-one, building blocks for the synthesis of macrolide antibiotics. Synlett 27, 57\u201360 (2016)","journal-title":"Synlett"},{"key":"BFnature17967_CR36","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1002\/anie.201400928","volume":"53","author":"IB Seiple","year":"2014","unstructured":"Seiple, I. B., Mercer, J. A. M., Sussman, R. J., Zhang, Z. & Myers, A. G. Stereocontrolled synthesis of syn-\u03b2-hydroxy-\u03b1-amino acids by direct aldolization of pseudoephenamine glycinamide. Angew. Chem. Int. Ed. 53, 4642\u20134647 (2014)","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnature17967_CR37","doi-asserted-by":"publisher","first-page":"12950","DOI":"10.1021\/ja076539f","volume":"129","author":"K Mikami","year":"2007","unstructured":"Mikami, K., Kawakami, Y., Akiyama, K. & Aikawa, K. Enantioselective catalysis of ketoester-ene reaction of silyl enol ether to construct quaternary carbons by chiral dicationic palladium(II) complexes. J. Am. Chem. Soc. 129, 12950\u201312951 (2007)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature17967_CR38","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1246\/cl.1973.1011","volume":"2","author":"T Mukaiyama","year":"1973","unstructured":"Mukaiyama, T., Narasaka, K. & Banno, K. New aldol type reaction. Chem. Lett. 2, 1011\u20131014 (1973)","journal-title":"Chem. Lett."},{"key":"BFnature17967_CR39","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1055\/s-0034-1378822","volume":"47","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z., Kitamura, Y. & Myers, A. G. An efficient directed Claisen reaction allows for rapid construction of 5,6-disubstituted 1,3-dioxin-4-ones. Synthesis 47, 2709\u20132712 (2015)","journal-title":"Synthesis"},{"key":"BFnature17967_CR40","unstructured":"Hauske, J. R. & Schulte, G. R. Desosamino derivatives of macrolides as immunosuppressants and antifungal agents. WO patent 1993018042 (1993)"},{"key":"BFnature17967_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/anie.201507357","volume":"55","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z., Fukuzaki, T. & Myers, A. G. Synthesis of D-desosamine and analogs by rapid assembly of 3-amino sugars. Angew. Chem. Int. Ed. 55, 523\u2013527 (2016)","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnature17967_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/ol990875m","volume":"1","author":"AE Leyes","year":"1999","unstructured":"Leyes, A. E. & Poulter, C. D. Synthesis of (R)-[2-2H]isopentenyl diphosphate and determination of its enantiopurity by 2H NMR spectroscopy in a lyotropic medium. Org. Lett. 1, 1067\u20131070 (1999)","journal-title":"Org. Lett."},{"key":"BFnature17967_CR43","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/anie.200353429","volume":"43","author":"Z Tan","year":"2004","unstructured":"Tan, Z. & Negishi, E.-i. An efficient and general method for the synthesis of \u03b1,\u03c9-difunctional reduced polypropionates by Zr-catalyzed asymmetric carboalumination: synthesis of the scyphostatin side chain. Angew. Chem. Int. Ed. 43, 2911\u20132914 (2004)","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnature17967_CR44","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1016\/S0040-4039(00)97925-5","volume":"31","author":"E Santaniello","year":"1990","unstructured":"Santaniello, E., Ferraboschi, P. & Grisenti, P. An efficient chemo-enzymatic approach to the enantioselective synthesis of 2-methyl-1,3-propanediol derivatives. Tetrahedr. Lett. 31, 5657\u20135660 (1990)","journal-title":"Tetrahedr. Lett."},{"key":"BFnature17967_CR45","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1016\/0040-4039(95)01955-H","volume":"36","author":"AS Thompson","year":"1995","unstructured":"Thompson, A. S., Corley, E. G., Huntington, M. F. & Grabowski, E. J. J. Use of an ephedrine alkoxide to mediate enantioselective addition of an acetylide to a prochiral ketone: asymmetric synthesis of the reverse transcriptase inhibitor L-743,726. Tetrahedr. Lett. 36, 8937\u20138940 (1995)","journal-title":"Tetrahedr. Lett."},{"key":"BFnature17967_CR46","doi-asserted-by":"crossref","unstructured":"Sato, F., Ishikawa, H., Watanabe, H., Miyake, T. & Sato, M. Specific hydromagnesiation of prop-2-ynylic alcohols. A simple and specific route to terpenoids. J. Chem. Soc. Chem. Commun. 718\u2013720 (1981)","DOI":"10.1039\/c39810000718"},{"key":"BFnature17967_CR47","unstructured":"Ashley, G. et al. Ketolide antibacterials. US patent 6,590,083 (2003)"},{"key":"BFnature17967_CR48","unstructured":"Antibiotic Resistance Threats in the United States, 2013. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf (CDC, US Dept Health and Human Services, 2013)"},{"key":"BFnature17967_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.1109755","volume":"308","author":"MG Charest","year":"2005","unstructured":"Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R. & Myers, A. G. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science 308, 395\u2013398 (2005)","journal-title":"Science"},{"key":"BFnature17967_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbpa.2016.03.011","volume":"32","author":"F Liu","year":"2016","unstructured":"Liu, F. & Myers, A. G. Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics. Curr. Opin. Chem. Biol. 32, 48\u201357 (2016)","journal-title":"Curr. Opin. Chem. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature17967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature17967","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature17967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:51:59Z","timestamp":1684417919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature17967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":50,"journal-issue":{"issue":"7603","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFnature17967"],"URL":"https:\/\/doi.org\/10.1038\/nature17967","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"7 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.B.S., Z.Z. and A.G.M. have filed three provisional patents and an international patent application: US 62\/061571, \u201814-Membered Ketolides and Methods of Their Preparation and Use\u2019; US 62\/138198, \u2018Macrolides with Modified Desosamine Sugars and Uses Thereof\u2019; US 62\/214774, \u2018Right Half Synthesis of 14-Membered Azaketolides\u2019; PCT\/US2014\/033025, \u2018Macrolides and Methods of Their Preparation and Use\u2019. A.G.M. declares that he is a founder, board member, and chairman of the scientific advisory board of Macrolide Pharmaceuticals, and Z.Z. and I.B.S. declare that they serve as scientific consultants to Macrolide Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}